Skip to main navigation Skip to search Skip to main content

Development of novel bifunctional agents with and without tumor imaging ability

  • Manivannan Ethirajan
  • , Michael Williams
  • , Norm Angelino
  • , Joseph R. Missert
  • , Ravindra K. Pandey
  • Roswell Park Cancer Institute

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Scopus citations

Abstract

Purpurinimides, derived from chlorophyll-a, are tumor avid, stable in vivo and show a strong absorption in the near IR region (700 nm) with a high singlet oxygen (>50%) producing efficiency. Such a characteristic could be useful in treating large and deeply seated tumors by photodynamic therapy (PDT). These long wavelength photosensitizers can be used as vehicles to deliver the imaging agents to tumors. Therefore, by linking suitable tumor imaging moiety with purpurinimide could produce a novel bifunctional agent, which could possess the desired photo physical properties for both tumor detection as well as photodynamic therapy. Such image guided therapy would represent an archetype for cancer treatment.

Original languageEnglish
Title of host publication12th World Congress of the International Photodynamic Association - Photodynamic Therapy
Subtitle of host publicationBack to the Future
DOIs
StatePublished - 2009
Event12th World Congress of the International Photodynamic Association - Photodynamic Therapy: Back to the Future - Seattle, WA, United States
Duration: Jun 11 2009Jun 15 2009

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume7380
ISSN (Print)1605-7422

Conference

Conference12th World Congress of the International Photodynamic Association - Photodynamic Therapy: Back to the Future
Country/TerritoryUnited States
CitySeattle, WA
Period06/11/0906/15/09

Keywords

  • cancer treatment
  • Cyanaine dye
  • Multifunctional agent
  • Optical imaging
  • PDT
  • Purpurinimides

Fingerprint

Dive into the research topics of 'Development of novel bifunctional agents with and without tumor imaging ability'. Together they form a unique fingerprint.

Cite this